Sarah T Kurz
Clinical Assistant Professor of Internal Medicine
Internal Medicine
1500 E Med Center Dr
Ann Arbor, MI 48109-5378
[email protected]

Available to mentor
Sarah T Kurz
Clinical Assistant Professor
  • About
  • Qualifications
  • Research Overview
  • Recent Publications
    • About

    Sarah Kurz, MD is a Clinical Assistant Professor of Medicine at the University of Michigan Medical School. Clinically, she works in adult Infectious Diseases where she has particular interests in HIV, endocarditis, sexually transmitted infections, and caring for patients who have co-morbid substance use.

    She earned her degree in medicine from the University of Michigan Medical School and completed residency in Internal Medicine and fellowship in Infectious Diseases at the University of Pennsylvania (Penn). While at Penn, she completed a fellowship in medical education.

    She enjoys reading, running, playing with her dog, and spending times with friends and family.

    Qualifications
    • Fellowship
      Hospital of the University of Pennsylvania, Philadelphia, 2022
    • Internship and Residency
      Hospital of the University of Pennsylvania, Philadelphia, 2020
    • M.D.
      University of Michigan Medical School, Ann Arbor, 2017
    • B.A.
      University of Pennsylvania, Philadelphia, 2013
    Research Overview

    •Clinical Coaching
    •Multidisciplinary approaches to treating patients who inject drugs

    Recent Publications See All Publications
    • Journal Article
      Developing a Medication for the Opioid Use Disorder Workforce in Primary Care Training
      Kurz S, Abernethy JL, Tate S, Shalaby M, Chertok J, Nandiwada DR. SGIM Forum, 2023 Mar; 46 (3): 7 - 7.
    • Journal Article
      Contemporary Management of Secondary Aortoduodenal Fistula.
      Howard R, Kurz S, Sherman MA, Underhill J, Eliason JL, Coleman DM. Ann Vasc Surg, 2015 Nov; 29 (8): 1614 - 1618. DOI:10.1016/j.avsg.2015.06.090
      PMID: 26318554
    • Journal Article
      Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC).
      Fury MG, Sherman EJ, Rao SS, Wolden S, Smith-Marrone S, Mueller B, Ng KK, Dutta PR, Gelblum DY, Lee JL, Shen R, Kurz S, Katabi N, Haque S, Lee NY, Pfister DG. Ann Oncol, 2014 Mar; 25 (3): 689 - 694. DOI:10.1093/annonc/mdt579
      PMID: 24496920
    • Proceeding / Abstract / Poster
      Contemporary Management of Secondary Aortoduodenal Fistula
      Howard R, Kurz S, Sherman M, Underhill J, Eliason J, Coleman DM, Howard presenter R. 2015 Jan 1;